[1] Hu C, Jia W. Diabetes in China:epidemiology and genetic risk factors and their clinical utility in personalized medication[J]. Diabetes, 2018, 67(1):3-11. [2] Fruci B, Giuliano S, Mazza A, et al. Nonalcoholic fatty liver:a possible new target for type 2 diabetes prevention and treatment[J]. Int J Mol Sci, 2013, 14(11):22933-22966. [3] Bader M,Santos R A, Unger T, et al. New therapeutic pathways in the RAS[J]. J Renin Angiotensin Aldosterone Sys, 2012,13(4):505-508. [4] Balakumar P, Jagadeesh G. A century old renin-angiotensin system still grows with endless possibilities:AT1 receptor signaling cascades in cardiovascular physiopathology[J]. Cell Signal, 2014, 26(10):2147-2160. [5] Santos R A,Simoese e Silva A C, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas[J]. Proc Natl Acad Sci U S A, 2003, 100(14):8258-8263. [6] Sampaio W O,Souza dos Santos R A, Faria-Silva R, et al. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways[J]. Hypertension, 2007, 49(1):185-192. [7] Becker L K, Etlvino G M, Walther T, et al. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain[J]. Am J Physiol Heart Circ Physiol, 2007,293(3):H1416-H1424. [8] Vaz-Silva J, Tavares R L, Ferreira M C, et al. Tissue specific localization of angiotensin-(1-7) and its receptor Mas in the uterus of ovariectomized rats[J]. J Mol Histol, 2012, 43(5):597-602. [9] Vaajanen A,Kalesnykas G, Vapaatalo H, et al. The expression of Mas-receptor of the renin-angiotensin system in the human eye[J]. Graefes Arch Clin Exp Ophthalmol, 2015, 253(7):1053-1059. [10] Cao X,Yang F Y, Yin Z, et al. The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance[J]. Mol Cell Endocrinol, 2014, 393(1-2):30-38. [11] Cao X,Yang F, Shi T, et al. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis[J]. Sci Rep, 2016, 6:21592. [12] Marciniak S J, Ron D. Endoplasmic reticulum stress signaling in disease[J]. Physiol Rev, 2006,86(4):1133-1149. [13] Kadowaki H, Nishitoh H. Signaling pathways from the endoplasmic reticulum and their roles in disease[J]. Genes (Basel), 2013,4(3):306-333. [14] Yu C,Cui, S, Zong C, et al. The orphan nuclear receptor NR4A1 protects pancreatic β-cells from endoplasmic reticulum (ER) stress-mediated apoptosis[J]. J Biol Chem, 2015, 290(34):20687-20699. [15] Waris G, Tardif K D, Siddiqui A. Endoplasmic reticulum (ER) stress:hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3[J]. Biochem Pharmacol, 2002, 64(10):1425-1430. [16] Zhang J, Li Y, Jiang S, et al. Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis[J]. Am J Physiol Cell Physiol, 2014, 306(3):C279-290. [17] Shi F H,Wu Y, Dai D Z, et al. Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver[J]. J Pharm Pharmacol, 2013, 65(6):916-927. [18] Mota M, Banini B A, Cazanave S C, et al. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease[J]. Metabolism, 2016,65(8):1049-1061. [19] Arumugam S, Thalavarayan R A, Palaniyandi S S, et al. Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats:involvement of ACE2-Ang (1-7)-mas axis[J]. Toxicology, 2012, 291(1-3):139-145. [20] Uhal B D, Nguyen H, Dang M, et al. Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 305(1):L33-L41. [21] Santos S H, Giani J F, Burghi V, et al. Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats[J]. J Mol Med (Berl), 2014, 92(3):255-265. [22] Santos S H, Braga J F, Mario E G, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7)[J]. Arterioscler Thromb Vasc Biol, 2010, 30(5):953-961. [23] Zhang F,Liu C, Wang L, et al. Antioxidant effect of angiotensin (17) in the protection of pancreatic beta cell function[J]. Mol Med Rep, 2016,14(3):1963-1969. [24] Santos R A S, Sampaio W O, Alzamora A C, et al. The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system:focus on angiotensin-(1-7)[J]. Physiol Rev, 2018, 98(1):505-553. [25] Liu C, LV X H, Li H X, et al. Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes[J]. Acta Diabetol, 2012, 49(4):291-299. [26] Santos S H, Fernandes L R, Mario E G, et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism[J]. Diabetes, 2008, 57(2):340-347. [27] Pinheiro S V B, Ferreira A J, Kihen G T, et al. Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria[J]. Kidney Int, 2009, 75(11):1184-1193. |